Back
Ultragenyx Pharmaceutical Stock Price Chart
Sponsored
RARE
Sponsored
Don't put a penny in AI stocks until you read this
Discover this under-the-radar AI stock now, ahead of the crowd.
Sell
47
RARE
Ultragenyx Pharmaceutical
Last Price:
54.79
Seasonality Move:
12.42%
7 Day Trial
ALL ACCESS PASS
$
7
Gold Set to Skyrocket as Fed Slashes Rates
Click here for the details on this incredible opportunity.- The current trend is moderately bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.
Ultragenyx Pharmaceutical Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 55.79 | Sell |
20-day SMA: | 55.04 | Sell |
50-day SMA: | 55.76 | Sell |
200-day SMA: | 47.58 | Buy |
8-day EMA: | 55.24 | Sell |
20-day EMA: | 55.36 | Sell |
50-day EMA: | 54.2 | Buy |
200-day EMA: | 48.52 | Buy |
Ultragenyx Pharmaceutical Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.03 | Sell |
Relative Strength Index (14 RSI): | 46.74 | Sell |
Chaikin Money Flow: | -417236 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (53.89 - 57.39) | Sell |
Bollinger Bands (100): | (42.72 - 56.34) | Buy |
Ultragenyx Pharmaceutical Technical Analysis
Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Ultragenyx Pharmaceutical Stock
Is Ultragenyx Pharmaceutical Stock a Buy?
- Ultragenyx Pharmaceutical share price is 54.69 while RARE 8-day simple moving average is 55.79, which is a Sell signal.
- The stock price of RARE is 54.69 while Ultragenyx Pharmaceutical 20-day SMA is 55.04, which makes it a Sell.
- Ultragenyx Pharmaceutical 50-day simple moving average is 55.76 while RARE share price is 54.69, making it a Sell technically.
- RARE stock price is 54.69 and Ultragenyx Pharmaceutical 200-day simple moving average is 47.58, creating a Buy signal.
RARE Technical Analysis vs Fundamental Analysis
Sell
47
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy or a Sell?
-
Ultragenyx Pharmaceutical stock is rated a Sell
The current Ultragenyx Pharmaceutical [RARE] share price is $54.69. The Score for RARE is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
Ultragenyx Pharmaceutical Stock Info
Market Cap:
5.04B
Price in USD:
54.69
Share Volume:
516.71K
Ultragenyx Pharmaceutical 52-Week Range
52-Week High:
60.37
52-Week Low:
31.52
Sell
47
Ultragenyx Pharmaceutical (RARE)
is a Sell
Ultragenyx Pharmaceutical Share Price Forecast
-
What is the Ultragenyx Pharmaceutical stock price today?
The Ultragenyx Pharmaceutical stock price is 54.69 USD today. -
Will RARE stock go up or go down?
Ultragenyx Pharmaceutical> share price is forecast to RISE/FALL based on technical indicators -
Is Ultragenyx Pharmaceutical overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Ultragenyx Pharmaceutical is overvalued.
Is Ultragenyx Pharmaceutical Stock a Buy?
- Ultragenyx Pharmaceutical share price is 54.69 while RARE 8-day exponential moving average is 55.24, which is a Sell signal.
- The stock price of RARE is 54.69 while Ultragenyx Pharmaceutical 20-day EMA is 55.36, which makes it a Sell.
- Ultragenyx Pharmaceutical 50-day exponential moving average is 54.20 while RARE share price is 54.69, making it a Buy technically.
- RARE stock price is 54.69 and Ultragenyx Pharmaceutical 200-day simple moving average is 48.52, creating a Buy signal.
Fundamental Analysis of Ultragenyx Pharmaceutical
Is Ultragenyx Pharmaceutical a good investment?
- Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.05 per share, and an increase next year of $1.10 per share.
Technical Analysis of Ultragenyx Pharmaceutical
Should I short Ultragenyx Pharmaceutical stock?
- RARE Moving Average Covergence Divergence (MACD) indicator is -0.03, suggesting Ultragenyx Pharmaceutical is a Sell
- Ultragenyx Pharmaceutical Relative Strength Index (RSI) is 46.74, which suggest Ultragenyx Pharmaceutical is oversold
- The Bollinger Bands (25) for Ultragenyx Pharmaceutical is (53.89 - 57.39), which suggest Ultragenyx Pharmaceutical is a Buy
- The Bollinger Bands (100) for Ultragenyx Pharmaceutical is (42.72 - 56.34), which suggest Ultragenyx Pharmaceutical is a Buy
* Ultragenyx Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.